You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic phase chronic myelogenous leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 24, 2022

Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
  • (no location specified)
Jun 7, 2022

Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 12, 2023

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Online Mindfulness Meditation
  • Internet-Based Webinars
  • San Francisco, California
    University of California San Francisco
Aug 9, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

Recruiting
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Chronic Phase Chronic Myelogenous Leukemia
  • Text Message-Based Navigation Intervention
  • Survey Administration
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 7, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

Not yet recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • APN and medical management
  • +3 more
  • Avignon, Provence-Alpes-Côte d'Azur, France
    Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Oct 13, 2023

Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Dasatinib Pill
  • Ketoconazole Pill
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. José Eleuterio González
Nov 25, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +11 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • Detroit, Michigan
  • +1 more
May 3, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +13 more
  • CMVpp65-A*0201 peptide vaccine
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

Leukemia, Chronic Myelogenous Trial in Japan (Bosutinib)

Completed
Has Results
  • Leukemia, Chronic Myelogenous
  • Toyoake-City, Aichi, Japan
  • +20 more
Apr 26, 2022

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Ponatinib in CML Patients in Chronic Phase

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Therapeutic drug monitoring
    • Molecular Response
    • Cagliari, Italy
    • +4 more
    Nov 3, 2023

    Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

    Recruiting
    • Chronic Myeloid Leukemia in Myeloid Blast Crisis
    • +3 more
    • based decitabine and olverembatinib（HQP1351)chemotherapy
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Dec 6, 2022

    Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Jena, Germany
        University Hospital Jena
      Jan 17, 2023

      Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

      Not yet recruiting
      • Leukemia
      • +12 more
      • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
      • (no location specified)
      Mar 20, 2023

      Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

      Active, not recruiting
      • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 2, 2022

      CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

      Recruiting
      • CML
      • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
      • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
        FUNDALEU
      Jun 29, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +36 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Jan 23, 2023

      Chronic Myelogenous Leukemia Trial in Beijing (TGRX-678)

      Recruiting
      • Chronic Myelogenous Leukemia
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jun 27, 2022

      Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

      Active, not recruiting
      • Acute Biphenotypic Leukemia
      • +18 more
      • Aurora, Colorado
      • +2 more
      Dec 28, 2022